Corcept Therapeutics Incorporated · NASDAQ:CORT
BlackRock, Inc. reported a 10.90% stake in Corcept Therapeutics Incorporated (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 10.90% stake in Corcept Therapeutics Incorporated, 11,539,099 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 10.90%
- Shares
- 11,539,099
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 10.90% | 11,539,099 |
Source
Related
- Corcept Therapeutics Incorporated
- BlackRock, Inc.
- Corcept Therapeutics Incorporated shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 23, 2025
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026